Roche's Quarterly Sales Declined 6% as a Slump in COVID Treatments and Diagnostic Testing ... - Latest Tweet by Reuters

The latest Tweet by Reuters states, 'Roche's quarterly sales declined 6% as a slump in COVID treatments and diagnostic testing outweighed gains from hemophilia and multiple sclerosis treatments ...'

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)

Share Now